What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?

Enrico De Lorenzis; Gerlando Natalello; Laura Gigante; Lucrezia Verardi; Silvia Laura Bosello; Elisa Gremese

doi:10.1016/j.autrev.2020.102666

What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?

Enrico De Lorenzis
, Gerlando Natalello
, Laura Gigante
, Lucrezia Verardi
, Silvia Laura Bosello
, Elisa Gremese^*

^*Corresponding author

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	102666-N/A
Journal	Autoimmunity Reviews
Volume	19
Issue number	11
DOIs	https://doi.org/10.1016/j.autrev.2020.102666
Publication status	Published - 2020

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology

Keywords

Anti-MDA5
COVID-19
Cytokines
Dermatomyositis
Inflammation
Interstitial lung disease

Access to Document

10.1016/j.autrev.2020.102666

Cite this

@article{46a2eb806d034e68a2ac40c8ec9c97ff,

title = "What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?",

keywords = "Anti-MDA5, COVID-19, Cytokines, Dermatomyositis, Inflammation, Interstitial lung disease, Anti-MDA5, COVID-19, Cytokines, Dermatomyositis, Inflammation, Interstitial lung disease",

author = "\{De Lorenzis\}, Enrico and Gerlando Natalello and Laura Gigante and Lucrezia Verardi and Bosello, \{Silvia Laura\} and Elisa Gremese",

year = "2020",

doi = "10.1016/j.autrev.2020.102666",

language = "English",

volume = "19",

pages = "102666--N/A",

journal = "Autoimmunity Reviews",

issn = "1568-9972",